longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Butterfly Network

BFLY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -27.75, below the reasonable range, cheaper than 88.49% of the time in the past 5 years, and the industry ranks 149/175, the industry Median -0.85.

-27.75xP/E
$7.80Stock price
$-0.28Earnings per share
-27.75xP/E
Stock price$7.80Earnings per share$-0.28

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.16x
Typical range
-14.01x–-2.31x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.53x141.71%$12.26B
GKOSUSGlaukos
-53.85x75.34%$10.13B
TFXUSTeleflex
-5.30x118.39%$5.47B
PLSEUSPulse Biosciences
-49.18x27.55%$3.94B
IRTCUSIRhythm
-264.42x71.96%$3.69B
AXGNUSAxogen
-78.65x31.25%$2.64B
BFLYUSButterfly Network
-27.75x34.41%$2.08B
ASSTUSStrive
-1.95x63.26%$1.91B
NVCRUSNovocure
-12.66x2.52%$1.88B
ATECUSAlphatec
-14.97x41.67%$1.65B
KMTSUSKestra Medical Tech
-9.85x0.94%$1.48B
DRTSUSAlpha Tau Medical
-14.83x--$1.37B
AORTUSArtivion
-387.79x266.67%$1.24B
IARTUSIntegra LifeSciences
-168.61x109.50%$1.22B
TNDMUSTandem Diabetes
-17.89x77.82%$1.13B
PRCTUSPROCEPT BioRobotics
-10.07x3.47%$1.11B
ENOVUSEnovis
-0.94x100.97%$1.03B
CBLLUSCeribell
-14.56x35.15%$960.99M
BBNXUSBeta Bionics
-11.86x17.19%$865.15M
SIBNUSSI-BONE
-56.82x8.85%$831.38M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.